Drug Profile
Research programme: vascular disrupting agents - Istesso/University of Bradford
Latest Information Update: 17 Jul 2019
Price :
$50
*
At a glance
- Originator University of Bradford
- Developer Istesso; University of Bradford
- Class
- Mechanism of Action Vascular disrupting agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 30 Jun 2008 Preclinical trials in Cancer in United Kingdom (unspecified route)